deferiprone has been researched along with Insulin Resistance in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone was the most effective chelator to improve glucose homeostasis in chronically transfused thalassemics." | 1.48 | Glucose Homeostasis and Effect of Chelation on β Cell Function in Children With β-Thalassemia Major. ( Bagmar, S; Dabas, A; Gomber, S; Madhu, SV, 2018) |
| "Diabetes mellitus is a common endocrinopathy in patients with β-thalassaemia major (β-TM), which is high prevalent in southern China." | 1.46 | Prevalence of diabetes mellitus in Chinese children with thalassaemia major. ( Bajoria, R; Chatterjee, R; Jiang, Y; Lai, Y; Liang, Y; Pan, H; Su, H; Xia, N, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, Y | 1 |
| Bajoria, R | 1 |
| Jiang, Y | 1 |
| Su, H | 1 |
| Pan, H | 1 |
| Xia, N | 1 |
| Chatterjee, R | 1 |
| Lai, Y | 1 |
| Gomber, S | 1 |
| Dabas, A | 1 |
| Bagmar, S | 1 |
| Madhu, SV | 1 |
2 other studies available for deferiprone and Insulin Resistance
| Article | Year |
|---|---|
Prevalence of diabetes mellitus in Chinese children with thalassaemia major.
Topics: Alanine Transaminase; beta-Thalassemia; Blood Glucose; Child; China; Deferiprone; Diabetes Mellitus; | 2017 |
Glucose Homeostasis and Effect of Chelation on β Cell Function in Children With β-Thalassemia Major.
Topics: Adolescent; beta-Thalassemia; Blood Glucose; Chelation Therapy; Child; Child, Preschool; Deferiprone | 2018 |